Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer's disease and progressive supranuclear palsy brains.

about

Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer's disease and progressive supranuclear palsy brains.

Item

http://www.wikidata.org/entity/Q42106758

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@en

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@nl

type

Item

label

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@en

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@nl

prefLabel

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@en

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@nl

P1476

Alternative promoter usage gen ...... ive supranuclear palsy brains.

@en

P2093

Claire-Marie Dhaenens

http://www.w3.org/2001/XMLSchema#string

Hélène Behal

http://www.w3.org/2001/XMLSchema#string

Julien Labreuche

http://www.w3.org/2001/XMLSchema#string

P2860

Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease

A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation

Fiji: an open-source platform for biological-image analysis.

Transcriptional activators differ in their abilities to control alternative splicing

Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene

SynGAP isoforms exert opposing effects on synaptic strength

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro

Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene.

P2888

s41598-017-12955-7

P304

12589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-12955-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luc Buée

Vincent Huin

Bernard Sablonniere

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092015829

http://www.w3.org/2001/XMLSchema#string

P698

28974731

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5626709

http://www.w3.org/2001/XMLSchema#string